FDA Inspection 1296524 — Jean Bergeron, MD, MSc, FRCPC
The FDA completed an inspection of Jean Bergeron, MD, MSc, FRCPC on December 12, 2025 in Quebec. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 12, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Quebec (Canada)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7385 | 21 CFR 50.25(b)(3) | Possible additional costs to the subject |
| 7392 | 21 CFR 50.25(a)(7) | Whom to contact |
| 7659 | 21 CFR 50.25(a)(6) | Compensation, medical treatment in event of injury |